Biomarkers for immunotherapy resistance in non-small cell lung cancer

Biomarkers for immunotherapy resistance in non-small cell lung cancer

Immunotherapy has revolutionised the treatment landscape of non-small cell lung cancer (NSCLC), significantly improving survival outcomes and offering renewed hope to patients with advanced disease. However, the majority of patients experience limited long-term benefits from immune checkpoint inhibi...

Full description

Saved in:

Bibliographic Details
Main Authors:	Catriona Rother, Tom John, Annie Wong
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2024-12-01
Series:	Frontiers in Oncology
Subjects:	non-small cell lung cancer (NSCLC) immunotherapy resistance precision oncology strategies biomarkers circulating biomarkers
Online Access:	https://www.frontiersin.org/articles/10.3389/fonc.2024.1489977/full
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Novel Approach to Proficiency Testing Reveals Significant Variations in Biomarker Practice Leading to Critical Differences in Lung Cancer Management
by: Kassandra R. Bisson, MHSc, et al.
Published: (2025-07-01)

Recent advances in biomarkers for predicting the efficacy of immunotherapy in non-small cell lung cancer
by: Jiacheng Zhang, et al.
Published: (2025-05-01)

Advances in biomarkers for immunotherapy in small-cell lung cancer
by: Hui Li, et al.
Published: (2024-12-01)

Unlocking the therapeutic potential of antibody–drug conjugates in targeting molecular biomarkers in non-small cell lung cancer
by: Shruti Soni, et al.
Published: (2025-03-01)

Retrospective analysis of inflammatory biomarkers and prognosis in non-small cell lung cancer without adenocarcinoma in situ
by: Qing Zhao, et al.
Published: (2025-03-01)

The Role of Eosinophils, Eosinophil-Related Cytokines and AI in Predicting Immunotherapy Efficacy in NSCLC
by: Fausto Omero, et al.
Published: (2025-03-01)

Blood-based biomarkers in patients with non-small cell lung cancer treated with immune checkpoint blockade
by: Yo-Ting Tsai, et al.
Published: (2024-03-01)

Biomarker-Driven Approaches to Bone Metastases: From Molecular Mechanisms to Clinical Applications
by: Youssef Elshimy, et al.
Published: (2025-05-01)

Keratin 80 as a diagnostic biomarker with limited prognostic value in non-small cell lung cancer
by: Ying Zeng, et al.
Published: (2025-06-01)

The impact of artificial intelligence on a multi-omics approach toward predictive biomarkers for non-small cell lung cancer
by: Brandon Wilkins, et al.
Published: (2025-06-01)

Unraveling the role of HDAC3 as an immunotherapy prognostic biomarker and therapeutic target in advanced non-small cell lung cancer
by: Liyuan Dai, et al.
Published: (2025-06-01)

Biomarkers for non-small cell lung cancer immunotherapy
by: D. A. Kharagezov, et al.
Published: (2021-09-01)

Biomarker testing in lung cancer: from bench to bedside
by: Ullas Batra, et al.
Published: (2025-01-01)

Serum extracellular vesicle microRNAs as potential biomarkers to predict pembrolizumab response and prognosis in metastatic non-small cell lung cancer patients
by: Daniela Lamorte, et al.
Published: (2025-06-01)

The Regulatory Role of LncRNAs in Modulating Autophagy and Drug Resistance in Non-Small-Cell Lung Cancer: Focus on Targeted Therapeutic Approaches
by: Shuncai Dai, et al.
Published: (2025-07-01)

Anti-ceramide antibody and sphingosine-1-phosphate as potential biomarkers of unresectable non-small cell lung cancer
by: Lilla Bűdi, et al.
Published: (2025-01-01)

Harnessing delta-like ligand 3: bridging biomarker discovery to next-generation immunotherapies in refractory small cell lung cancer
by: Kangkang Ji, et al.
Published: (2025-05-01)

Immunotherapy for Extensive-stage Small Cell Lung Cancer:  Research Progress and Future Perspectives
by: Yuling ZHONG, et al.
Published: (2024-11-01)

Three Circulating miRNAs Related to Non-Small-Cell Lung Cancer Progression: An Integrative Analysis of Their Biological Roles
by: Yanqin Niu, et al.
Published: (2025-04-01)

Osteopontin is a prognostic biomarker in non-small cell lung cancer
by: Ane Kongsgaard, et al.
Published: (2013-11-01)

Integrative profiling of lung cancer biomarkers EGFR, ALK, KRAS, and PD-1 with emphasis on nanomaterials-assisted immunomodulation and targeted therapy
by: Li Peng, et al.
Published: (2025-08-01)

Continuous immunotherapy beyond disease progression in patients with advanced non-small cell and small cell lung cancer
by: Jing Cheng, et al.
Published: (2025-02-01)

Early kinetics of serum amyloid A predict clinical benefit to first-line chemoimmunotherapy and immunotherapy in advanced non-small cell lung cancer: a retrospective analysis
by: Wei Du, et al.
Published: (2025-05-01)

Biomarkers and ImmuneScores in lung cancer: predictive insights for immunotherapy and combination treatment strategies
by: Xiaoyu Yang, et al.
Published: (2025-07-01)

Recent advances in therapeutic strategies for non-small cell lung cancer
by: Po-Lan Su, et al.
Published: (2025-03-01)

Immunological biomarkers and gene signatures predictive of radiotherapy resistance in non-small cell lung cancer
by: Jie Lv, et al.
Published: (2025-05-01)

<i>NALCN</i> Promoter Methylation as a Biomarker for Metastatic Risk in a Cohort of Non-Small Cell Lung Cancer Patients
by: Eleni Thanou, et al.
Published: (2024-11-01)

The possibilities of combination immunotherapy with radiation therapy for the treatment of patients with inoperable locally advanced non-small cell lung cancer
by: E. I. Smolenov, et al.
Published: (2021-06-01)

Vascular endothelial growth factor (VEGF) as a diagnostic marker of non-small cell lung cancer
by: Noor Mey Wardhani, et al.
Published: (2025-05-01)

Identification of a Biomarker Panel in Extracellular Vesicles Derived From Non‐Small Cell Lung Cancer (NSCLC) Through Proteomic Analysis and Machine Learning
by: Ye Yuan, et al.
Published: (2025-05-01)

Intratumor heterogeneity related signature for clinical outcome and immunotherapy advantages in lung adenocarcinoma
by: Yanhua Zuo, et al.
Published: (2025-03-01)

Costs of biomarker testing in advanced non‐small cell lung cancer: a global study comparing next‐generation sequencing and single‐gene testing
by: Umberto Malapelle, et al.
Published: (2025-03-01)

Perioperative Chemo/Immunotherapies in Lung Cancer: A Critical Review on the Value of Perioperative Sequences
by: Thoma’ Dario Clementi, et al.
Published: (2025-07-01)

Cancer-associated macrophage-like cells as a prognostic biomarker in solid tumors
by: Anthony Pirrello, et al.
Published: (2024-12-01)

The prognostic and clinicopathological value of HALP score in non-small cell lung cancer
by: Qin Li, et al.
Published: (2025-06-01)

LRP1B Suppresses Immunotherapy Efficacy in Lung Adenocarcinoma by Preventing Ferroptosis
by: Zi‐Hao Ke, et al.
Published: (2024-12-01)

Multi-omics unveils BCAA metabolism markers L-leucine and HMGCS1 as prognostic marker for immunotherapy efficacy in non-small cell lung cancer
by: Liyuan Dai, et al.
Published: (2025-06-01)

Emerging research themes in ferroptosis research for non-small cell lung cancer: a bibliometric and visualized analysis
by: Wenbo Zhang, et al.
Published: (2025-05-01)

Circulating genomic biomarkers predict chemoradiotherapy resistance and immunotherapy response in locally advanced non‐small‐cell lung cancer
by: Yu Wang, et al.
Published: (2025-06-01)

PTPRC is an immunotherapeutic predictor and serum biomarker in lung adenocarcinoma correlated with immune cell infiltration
by: Yongwang Hou, et al.
Published: (2025-08-01)